The global diabetes devices market size is expected to reach around US$ 48.8 billion by 2030 from US$ 26.7 billion in 2020 and is expected to grow at an impressive double-digit rate of 6.2% from 2021 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global diabetes devices market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.
Crucial factors accountable for market growth are:
- Growing prevalence of diabetes
- Unhealthy food habits and sedentary lifestyle
- Growing awareness regarding diabetes control
- Rapid growth of online pharmacy
- Rapidly increasing diabetic population in underdeveloped and developing nations
- Technological advancements and developments in the diabetes management devices
We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1321
Report Highlights
- By type, the insulin delivery devices segment led the global diabetes devices market owing to the higher adoption of insulin pen among the consumers. The convenience and comfort of injecting insulin helps to control diabetes in today’s busy and hectic lifestyle without applying much efforts.
- By distribution channel, the hospital pharmacy segment led the global diabetes devices market with remarkable revenue share in 2020. The hospital pharmacists provide proper counseling to their patients regarding the product and their appropriate time to take medications. Hence, the diabetes related services provide by the pharmacists has fostered the segmental growth.
- By end use, the hospital segment led the global diabetes devices market because most of the frequent hospital visits and admissions of the diabetic patients and hence, the use of diabetes device is more in hospitals.
Regional Snapshots
The global diabetes devices market is dominated by the North America, closely followed by Europe and Asia Pacific regions. North America is a matured market for the diabetes devices because a decline in the rate of diabetic population has been witnessed in the US since 2008. New diabetes cases in the US is prevailing among the Hispanic and non-Hispanic black population, the immigrant population. Increased awareness regarding diabetes, high disposable income, increasing consumer expenditure on healthcare products, developed healthcare infrastructure, and higher adoption rate of technologically advanced products in North America has exponentially contributed towards the growth of the diabetes devices market in the region.
The prevalence of type 2 diabetes is rapidly growing in the low and middle income countries that makes the Asia Pacific and Africa the most opportunistic market for the diabetes devices. Furthermore, rising government expenditure for the development of sophisticated healthcare infrastructure and increase in the marketing and promotional activities by the private brands is significantly grabbing the attention of the geriatric population and stimulating them to make a purchase of the diabetes device. Moreover, development of advanced and low cost devices is significantly boosting the adoption rate of the diabetes devices among the population.
Why should you invest in this report?
If you are aiming to enter the global diabetes devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for diabetes devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global diabetes devices market include:
- B Braun Melsungen AG
- Abbott Laboratories
- Bayer AG
- Medtronic Plc
- F.Hoffman-La-Ltd.
- Lifescan, Inc.
- Dexcom, Inc.
- Sanofi
- Tandem Diabetes Care, Inc.
- Companion Medical
Market Segmentation:
By Type
- Blood Glucose Monitoring
- Self-Monitoring
- Continuous Glucose Monitoring
- Insulin Delivery Devices
- Pens
- Pumps
- Jet Injectors
- Syringes
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Clinics
- Online Pharmacy
- Others
By End Use
- Diagnostic Center
- Hospitals
- Home Care
Regional Analysis:
The geographical analysis of the global diabetes devices market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global diabetes devices Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global diabetes devices market in 2030?
- What is the expected CAGR for the diabetes devices market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global diabetes devices market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Diabetes Devices Market, By Type
7.1. Diabetes Devices Market, by Type, 2021-2030
7.1.1. Blood Glucose Monitoring
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Insulin Delivery Devices
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Diabetes Devices Market, By Application
8.1. Diabetes Devices Market, by Application, 2021-2030
8.1.1. Diagnostic Center
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Home Care
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Diabetes Devices Market, By Distribution Channel
9.1. Diabetes Devices Market, by Distribution Channel, 2021-2030
9.1.1. Retail Pharmacy
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Hospital Pharmacy
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Clinics
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Online Pharmacy
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Diabetes Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
Chapter 11. Company Profiles
11.1. B Braun Melsungen AG
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbott Laboratories
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bayer AG
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Medtronic Plc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. F.Hoffman-La-Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Lifescan, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Dexcom, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Sanofi
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Tandem Diabetes Care, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Companion Medical
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1321
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments